Eyougene Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 400

Employees

  • Latest Deal Type
  • Series B

  • Investors
  • 3

Eyougene General Information

Description

Developer of pharmaceutical intermediates and specialty chemical compounds intended to support drug development and advanced material production. The company offers contract research and development manufacturing services spanning nutraceutical ingredients, active pharmaceutical intermediates, and fine chemical synthesis, enabling pharmaceutical companies, biotechnology firms, and healthcare institutions to accelerate drug development pipelines and strengthen supply chain reliability.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 5, Lane 1800, Xinyang Road, Lingang New Area
  • China Pilot Free Trade Zone
  • Shanghai, 201306
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Corporate Office
  • Building 5, Lane 1800, Xinyang Road, Lingang New Area
  • China Pilot Free Trade Zone
  • Shanghai, 201306
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eyougene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series B) 11-Jan-2023 Completed Generating Revenue
1. Corporate 17-Feb-2021 Completed Generating Revenue
To view Eyougene’s complete valuation and funding history, request access »

Eyougene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Eyougene Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Hangzhou Huadian Investment Management Venture Capital Minority
LingDu Capital Corporate Venture Capital Minority
Starry Pharmaceutical Corporation Minority
To view Eyougene’s complete investors history, request access »

Eyougene Acquisitions (1)

Eyougene’s most recent deal was a Merger/Acquisition with Hangzhou Foster. The deal was made on 28-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hangzhou Foster 28-Mar-2023 Merger/Acquisition Pharmaceuticals
To view Eyougene’s complete acquisitions history, request access »

Eyougene FAQs

  • When was Eyougene founded?

    Eyougene was founded in 2015.

  • Where is Eyougene headquartered?

    Eyougene is headquartered in Shanghai, China.

  • What is the size of Eyougene?

    Eyougene has 400 total employees.

  • What industry is Eyougene in?

    Eyougene’s primary industry is Drug Discovery.

  • Is Eyougene a private or public company?

    Eyougene is a Private company.

  • What is Eyougene’s current revenue?

    The current revenue for Eyougene is .

  • How much funding has Eyougene raised over time?

    Eyougene has raised $5.88M.

  • Who are Eyougene’s investors?

    Hangzhou Huadian Investment Management, LingDu Capital, and Starry Pharmaceutical have invested in Eyougene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process